Jounce Therapeutics, Inc.

JPMORGAN CHASE & CO

Report date

3/31/2023

Quarter

2023 Q1

Filed

5/18/2023

Shares

1,136,847

Value ($000)

2,104

Weight

0.0%

2019 Q4 - 2023 Q1 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	5/18/2023	2,104	0.0%	1,136,847	3/31/2023
2022 Q4	2/13/2023	278	0.0%	250,208	12/31/2022
2022 Q3	11/14/2022	585	0.0%	250,067	9/30/2022
2022 Q2	8/11/2022	790	0.0%	260,570	6/30/2022
2022 Q1	5/11/2022	1,524	0.0%	224,384	3/31/2022
2021 Q4	2/11/2022	2,203	0.0%	263,893	12/31/2021
2021 Q3	11/12/2021	2,173	0.0%	292,425	9/30/2021
2021 Q2	8/12/2021	2,245	0.0%	330,303	6/30/2021
2021 Q1	5/12/2021	1,698	0.0%	165,275	3/31/2021
2020 Q4	2/19/2021	853	0.0%	121,789	12/31/2020
2020 Q3	11/12/2020	1,034	0.0%	125,807	9/30/2020
2020 Q2	8/11/2020	935	0.0%	135,397	6/30/2020
2020 Q1	5/12/2020	716	0.0%	150,738	3/31/2020
2019 Q4	2/11/2020	1,527	0.0%	174,937	12/31/2019